The hallucinations and delusions experienced as a complication of Parkinson’s disease often result in nursing home admissions. In this practical and interactive educational activity, you will follow 2 long-term care residents. Learn how to successfully navigate real scenarios encountered in caring for residents with Parkinson’s disease psychosis. You will be introduced to the residents through shift change rounds and decide on the optimal paths to take for best practices in communications, staff interactions, and treatment approaches to improve outcomes for these challenging residents.
Identifying and Managing Distress in the Elderly With Parkinson’s Disease: Navigating Care Options
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Identifying and Managing Distress in the Elderly With Parkinson’s Disease: Navigating Care Options
Share this program on:
Choose a format
Take Post-TestSkip straight to the post-test if you have already participated in this activity
Media formats available:
Details
Presenters
Comments
Overview
Disclosure of Conflicts of Interest
Disclosure Policy
Amedco requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to Amedco policy. Amedco is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.Faculty
Fay Hardison Bembry, RN, MSN, is on the speakers bureau for ACADIA Pharmaceuticals Inc, Avanir Pharmaceuticals, Inc, and Myriad Genetics, Inc.Dana Saffel, PharmD, is a consultant for ACADIA Pharmaceuticals Inc, Neurocrine Biosciences, Inc, Sun Pharmaceutical Industries, Inc, Sunovion Pharmaceuticals Inc, Xeris Pharmaceuticals, Inc, and Viatris Inc.
Peer Reviewer
This activity was peer reviewed. The peer reviewer has no relevant financial relationships.Planners and Managers
MedEdicus planners and managers have no relevant commercial relationships to disclose.Target Audience
This activity intends to educate directors of nursing, nurse practitioners, and nurses caring for patients with Parkinson’s disease in the long-term care setting.
Learning Objectives
After completing this activity, participants will be better able to:
- Effectively communicate strategies for assessing symptoms of psychosis in residents with Parkinson’s disease
- Update an individualized plan of care for long-term care residents with Parkinson’s disease who experience psychosis
Accreditation and Credit Designation Statements
Interprofessional Joint Accreditation Statement
In support of improving patient care, Amedco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Nursing Credit
The maximum number of hours awarded for this Continuing Nursing Education Activity is 0.5 contact hour.Disclaimer
Instructions for Obtaining Credit
To obtain CE credit for this activity, please participate in the activity, consult referenced sources as necessary, and complete the posttest and evaluation online. Upon passing, a certificate will be made available immediately.Off-Label Discussion
This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC, Amedco, or ACADIA Pharmaceuticals Inc.This CE activity is copyrighted to MedEdicus LLC ©2022. All rights reserved. 262.2
Provider(s)/Educational Partner(s)
This continuing education activity is provided by Amedco in collaboration with MedEdicus LLC.
For questions about this educational activity, please contact MedEdicus LLC at info@mededicus.com.
MedEdicus Privacy Policy: https://mededicus.com/privacy-policy.php
Commercial Support
This continuing education activity is supported through an educational grant from ACADIA Pharmaceuticals Inc.
System Requirements
Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.
Publication Dates
Release Date:
Expiration Date:
Recommended
Details
Presenters
Comments
Recommended
Overview
The hallucinations and delusions experienced as a complication of Parkinson’s disease often result in nursing home admissions. In this practical and interactive educational activity, you will follow 2 long-term care residents. Learn how to successfully navigate real scenarios encountered in caring for residents with Parkinson’s disease psychosis. You will be introduced to the residents through shift change rounds and decide on the optimal paths to take for best practices in communications, staff interactions, and treatment approaches to improve outcomes for these challenging residents.
Disclosure of Conflicts of Interest
Disclosure Policy
Amedco requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to Amedco policy. Amedco is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.Faculty
Fay Hardison Bembry, RN, MSN, is on the speakers bureau for ACADIA Pharmaceuticals Inc, Avanir Pharmaceuticals, Inc, and Myriad Genetics, Inc.Dana Saffel, PharmD, is a consultant for ACADIA Pharmaceuticals Inc, Neurocrine Biosciences, Inc, Sun Pharmaceutical Industries, Inc, Sunovion Pharmaceuticals Inc, Xeris Pharmaceuticals, Inc, and Viatris Inc.
Peer Reviewer
This activity was peer reviewed. The peer reviewer has no relevant financial relationships.Planners and Managers
MedEdicus planners and managers have no relevant commercial relationships to disclose.Target Audience
This activity intends to educate directors of nursing, nurse practitioners, and nurses caring for patients with Parkinson’s disease in the long-term care setting.
Learning Objectives
After completing this activity, participants will be better able to:
- Effectively communicate strategies for assessing symptoms of psychosis in residents with Parkinson’s disease
- Update an individualized plan of care for long-term care residents with Parkinson’s disease who experience psychosis
Accreditation and Credit Designation Statements
Interprofessional Joint Accreditation Statement
In support of improving patient care, Amedco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Nursing Credit
The maximum number of hours awarded for this Continuing Nursing Education Activity is 0.5 contact hour.Disclaimer
Instructions for Obtaining Credit
To obtain CE credit for this activity, please participate in the activity, consult referenced sources as necessary, and complete the posttest and evaluation online. Upon passing, a certificate will be made available immediately.Off-Label Discussion
This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC, Amedco, or ACADIA Pharmaceuticals Inc.This CE activity is copyrighted to MedEdicus LLC ©2022. All rights reserved. 262.2
Provider(s)/Educational Partner(s)
This continuing education activity is provided by Amedco in collaboration with MedEdicus LLC.
For questions about this educational activity, please contact MedEdicus LLC at info@mededicus.com.
MedEdicus Privacy Policy: https://mededicus.com/privacy-policy.php
Commercial Support
This continuing education activity is supported through an educational grant from ACADIA Pharmaceuticals Inc.
System Requirements
Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.
Publication Dates
Release Date:
Expiration Date:
Facebook Comments